Peyronlab researchers are dedicated to the study of stem cells and resistance mechanisms in childhood leukemia

Latest contributions:

• Combination of PKCδ Inhibition with Conventional TKI Treatment to Target CML Models
  Fabien Muselli, Lucas Mourgues, Rita Morcos, Nathalie Rochet, Marielle Nebout, Agnès Guerci-Bresler, Douglas V Faller, Robert M William,
  Rana Mhaidly, Els Verhoeyen, Laurence Legros, Jean-François Peyron, and Didier Mary
  Cancers 2021
• New drug repositioning candidates for T-ALL identified via human/murine gene signature comparison
  Raphael Bonnet, Marielle Nebout, Carine Brousse, Frederic Reinier, Veronique Imbert, Pierre Simon Rohrlich and Jean-Francois Peyron
  Front Oncol. 2020
• Targeting the Human 80S Ribosome in Cancer: From Structure to Function and Drug Design for Innovative Adjuvant Therapeutic Strategies
  Gilles A, Frechin L, Natchiar K, Biondani G, Loeffelholz OV, Holvec S, Malaval JL, Winum JY, Klaholz BP, Peyron JF
  Cells 2020
• Druggable Biochemical Pathways and Potential Therapeutic Alternatives to Target Leukemic Stem Cells and Eliminate the Residual Disease in Chronic Myeloid Leukemia
  Fabien Muselli, Jean-François Peyron, Didier Mary
  Int J Mol Sci. 2019

Meet the team:

Team leader

Jean-François Peyron

Researcher

Biologists

Clinicians

Pierre-Simon Rohrlich

Pediatrician

Join the team !